
Jazmin Holdway
Jazmin Holdway is a communications specialist at Boston Medical Center. She holds a MS in Public Relations from Boston University.
Recent Posts

COVID-19 Safety Measures May Have Led to Increased Gun Injuries in Boston
Study on trends in violent injuries treated at Boston Medical Center suggests fallout from the pandemic’s first wave hit vulnerable communities hardest.

New Guidance Helps Manage Heart Disease Risk After Pregnancy Complications
The recommendations provide a comprehensive resource for primary care clinicians to identify and counsel postpartum patients who are at risk.

Pandemic Led to a Surge in Depression and Anxiety Among Children of Color
Researchers say new prevention and therapeutic programs are needed to mitigate the psychosocial impact of COVID-19 on families of color.

Autistic People of Color Serve as Clinical Research Advisors in a New Project
Diversity in clinical research is essential, but often missing. Engaging autistic BIPOC adults as partners in autism research will build more effective, inclusive studies for better healthcare.

New Findings Point to a Promising HIV Vaccine Research Path
The immune response known as ADCC is associated with protection against transmission of the virus, research from BMC shows.

6 Stages of Engagement Framework May Help Better Treat Children with ADHD
A new study, focusing on pediatric ADHD patients of color, could help inform treatment strategies that are more effective for the specific needs of these children and families.

Systemic Racism in the U.S. Affects All Mothers and Their Babies, Study Suggests
A new study of BMC patients shows that birthing people born in the U.S. have an increased risk of adverse perinatal outcomes compared to patients born outside of the country.

BMC's New Long COVID Clinic Aims to More Holistically Treat Patients
Caring for patients with long COVID symptoms requires the attention of many clinical departments to support the physical, mental, and social implications.

Inadequate Cervical Cancer Screening Puts Women 65+ at Risk
Guidelines recommend discontinuing cervical cancer screening at 65, but new research shows that the majority of women don't meet the criteria to stop.

People Who Inject Drugs Need Accessible PrEP, MOUD Information
A study reveals that people at a drug detoxification site were unaware of HIV pre-exposure prophylaxis, or PrEP, but were enthusiastic when informed.